ISIDORe II

Funding programme: Horizon Europe

Coordinator: European Research Infrastructure on Highly Pathogenic Agents (ERINHA)

Budget: €10,456,496.25

Duration: 1 June 2026 – 31 May 2029

ISIDORe II: Integrated Services for Infectious Disease Outbreak Research II is the continuation of ISIDORe and aims to strengthen Europe’s research infrastructure capacity for pandemic preparedness and response. 

The project provides coordinated transnational and virtual access to research services supporting work on epidemic- and pandemic-prone pathogens, medical countermeasures, FAIR data, Open Science, and One Health.

The project consolidates a more strategic and integrated access model, combining infectious disease-focused research infrastructures with transversal infrastructures offering technologies such as imaging, omics, structural biology, drug discovery, ex vivo models, and clinical research support. ISIDORe II will use a unified service catalogue and access platform to help users identify and access the most relevant services across the consortium.

ISIDORe II also focuses on improving the scientific, ethical, regulatory, and translational value of user projects, embedding FAIR data stewardship and strengthening alignment with European and global preparedness actors such as HERA, ECDC, WHO, DURABLE, and the BE READY NOW Partnership.

Consortium 

The ISIDORe II consortium brings together a broad network of European research infrastructures and scientific organisations with complementary expertise across infectious diseases, translational medicine, clinical research, biobanking, imaging, structural biology, data management, epidemiology, and medical countermeasure development.

The consortium integrates high-containment facilities, transnational access services, translational and clinical research infrastructures, and advanced technology platforms to provide coordinated support for epidemic and pandemic preparedness research. Through this multidisciplinary and cross-infrastructure approach, ISIDORe II aims to accelerate infectious disease research and strengthen Europe’s long-term preparedness and response capacity. 

ECRIN's role in ISIDORe II

ECRIN supports ISIDORe II by providing expert advice on regulatory and clinical trial aspects, helping researchers and SMEs progress from early development to clinical studies in the context of pandemic preparedness. It offers tailored guidance on regulatory requirements, trial authorisation, study design across all phases, and funding strategies for multinational clinical studies in Europe, and connects the research community with European networks, including the “Be Ready” network. These services accelerate the clinical testing of vaccines, therapeutics, and diagnostics and contribute to a comprehensive and accessible service offer for the research community.